Updated predictive analysis of the WHO-defined molecular subgroups of low-grade gliomas within the high-risk treatment arms of NRG Oncology/RTOG 9802.

被引：4

作者：

Bell, Erica Hlavin

Won, Minhee

Fleming, Jessica L.

Becker, Aline P.

McElroy, Joseph P.

Shaw, Edward G.

Mehta, Minesh P.

Brachman, David G.

Gertler, Stanley Z.

Murtha, Albert D.

Schultz, Christopher J.

Johnson, David B.

Laack, Nadia N.

Hunter, Grant Kirton

Crocker, Ian R.

Chakravarti, Arnab

机构：

[1] Ohio State Univ, Columbus, OH 43210 USA

[2] NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA

[3] Wake Forest Sch Med, Winston Salem, NC 27101 USA

[4] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA

[5] St Joesphs Hosp & Med Ctr, Phoenix, AZ USA

[6] Ottawa Hosp & Canc Ctr, Ottawa, ON, Canada

[7] Cross Canc Inst, Edmonton, AB, Canada

[8] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[9] St Francis Reg West Medcl Ctr, Lagrange, WY USA

[10] Mayo Clin, Rochester, MN USA

[11] Intermt Healthcare, Murray, UT USA

[12] Emory Univ Hosp, Winship Canc Inst, 1364 Clifton Rd NE, Atlanta, GA 30322 USA

来源：

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.2002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2002

引用

页数：2